ENABLEX is a prescription medicine thats been proven to treat the symptoms of Overactive Bladder, including:
Strong, sudden urges you must find a bathroom immediately (also called "urgency").
Frequent bathroom trips more than 8 times in 24 hours (also called "urinary frequency").
Unexpected, sudden leaking or wetting accidents (also called "urinary incontinence").
By targeting specific receptors on the bladder that cause involuntary muscle spasms, ENABLEX helps control the bladder muscle and helps restore control of urination.
ENABLEX (Darifenacin) is an M3 selective receptor antagonist (M3 SRA), which works by selectively blocking an important receptor involved in the control of bladder muscle contraction. ENABLEX (Darifenacin), a new oral treatment for overactive bladder (OAB), has the potential to prolong warning time the period between the first sensation of urgency and urination in patients experiencing OAB syndrome.
ENABLEX decreases the severity and frequency of urges, allowing you to go to the bathroom fewer times per day.
ENABLEX helps your bladder hold more urine before you feel the need to urinate.
ENABLEX may begin to relieve symptoms in as little as 2 weeks.
Its important to take ENABLEX as directed by your doctor, the same dose every day. Missed doses can lead to a recurrence of your symptoms and may delay improvement in your condition, so keep up with your treatment.
The most frequently reported side effects of ENABLEX are dry mouth, constipation, indigestion, and abdominal pain. Less frequently, people may experience blurred vision. The majority of side effects experienced by people taking ENABLEX are mild to moderate, and most occur during the first 2 weeks of treatment. In studies, few people stopped taking the medication because of the side effects.